2,957
Participants
Start Date
December 1, 2023
Primary Completion Date
December 1, 2023
Study Completion Date
December 1, 2023
This was an observational study without any intervention
This was an observational study without any intervention
Sichuan Cancer Hospital and Research Institute, Chengdu
Yongtao Han
OTHER